Stocks higher on vaccine optimism - Monday Review, March 1

Stocks higher on vaccine optimism - Monday Review, March 1

European and Asian manufacturing data impressed investors

The US

The stocks closed higher, driven by positive vaccine news and stimulus progress. USA30 added 2.1%, and USA500 was up 2.6%. TECH100 jumped 2.9%.

Crude oil traded at $62.66 per barrel after it went up 1.9%.

Gold settled at $1,723 per ounce after it lost 0.3%, marking the fifth consecutive session loss.

Asia and Australia

HongKong45 gained 0.72% as investors were awaiting the outcome of the Hang Seng Indexes Co. industry meeting over the proposed changes to the index.

Japan225 jumped 2.19% after the manufacturing PMI reading of 51.4 in February came above the 50.6 forecasted.

Down under, Australia200 rose 1.15% as the Reserve Bank is due to hand down its monetary policy on Tuesday.

Europe

Germany30 traded 1.1% higher. France40 rose 1.5%, and UK100 climbed 1.7%. The PMI data came in higher than forecasted at 57.9 in February from a previous 54.8.

Brent oil rose 1.9% to $65.63 per barrel.

EUR/USD traded at 1.2051 after it lost 0.2%.

Sources: reuters.com, investing.com

The information presented herein is prepared by CAPEX.com and does not intend to constitute Investment Advice. The information herein is provided as a general marketing communication for information purposes only and as such it has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research.

Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation.

Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance is not a reliable indicator of future results.